BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 29552863)

  • 1. [Development strategy of Paris based on combination of domestic patent and current resource application and development].
    Zhao FY; Tao AE; Xia CL
    Zhongguo Zhong Yao Za Zhi; 2018 Jan; 43(2):404-409. PubMed ID: 29552863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Patented technology status quo and development trend for Chinese herbal medicines].
    Li C; Huang L
    Zhongguo Zhong Yao Za Zhi; 2009 Jun; 34(11):1468-72. PubMed ID: 19771885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of patent data of Panax notoginseng and enlightenment of industrial development].
    Li G; Chen J; Li ZK; Wu W; Yang HJ
    Zhongguo Zhong Yao Za Zhi; 2020 Mar; 45(5):1011-1022. PubMed ID: 32237440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Present situation and development strategy of Alpinia oxyphylla].
    Yan XX; Ren BL; Wang MY; Wang QL; Yang Q; Tang H; Wang ZN
    Zhongguo Zhong Yao Za Zhi; 2019 May; 44(9):1960-1964. PubMed ID: 31342727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linking resource supplies and price drivers: Lessons from Traditional Chinese Medicine (TCM) price volatility and change, 2002-2017.
    Cunningham AB; Long X
    J Ethnopharmacol; 2019 Jan; 229():205-214. PubMed ID: 30339980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analyses on positive influence of harmonous development of traditional Chinese medicine compounds' researchs and patent protection].
    Yang X; Xiao S; Guo Z; Wang Z; You Y
    Zhongguo Zhong Yao Za Zhi; 2012 Jan; 37(1):9-12. PubMed ID: 22741453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current situation and consideration of patent protection in classical representative famous prescriptions in China].
    Zhao SM; Song JX; DU MB; Yuan YN
    Zhongguo Zhong Yao Za Zhi; 2019 Sep; 44(18):4067-4071. PubMed ID: 31872747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Resources industrialization channels and strategies of active polysaccharide from Lycii Fructus based on analysis of domestic and foreign intellectual properties].
    Zhang F; Guo S; Qian DW; Zhang X; Yang XC; Li YJ; Duan JA
    Zhongguo Zhong Yao Za Zhi; 2016 Dec; 41(23):4285-4291. PubMed ID: 28933102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paris in the spring: A review of the trade, conservation and opportunities in the shift from wild harvest to cultivation of Paris polyphylla (Trilliaceae).
    Cunningham AB; Brinckmann JA; Bi YF; Pei SJ; Schippmann U; Luo P
    J Ethnopharmacol; 2018 Aug; 222():208-216. PubMed ID: 29727736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of Authentication Evaluation Techniques of Ethnobotanical Medicinal Plant Genus
    Pei Y; Zhang Q; Wang Y
    Crit Rev Anal Chem; 2020; 50(5):405-423. PubMed ID: 31357868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Application of traditional Chinese patent drugs in cancer treatment].
    Li PW
    Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):400. PubMed ID: 21875476
    [No Abstract]   [Full Text] [Related]  

  • 12. [Medicinal values and their chemical bases of Paris].
    Wang YH; Niu HM; Zhang ZY; Hu XY; Li H
    Zhongguo Zhong Yao Za Zhi; 2015 Mar; 40(5):833-9. PubMed ID: 26087542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis on regional distribution characteristics and changing trend of Chinese patent medicine industry].
    Wang H; Zhang XB; Zhao YP; Shi TT; Yang G
    Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(14):2814-2819. PubMed ID: 29098843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development trend of traditional Chinese medicine resources].
    Huang L; Peng H; Xiao P
    Zhongguo Zhong Yao Za Zhi; 2011 Jan; 36(1):1-4. PubMed ID: 21473142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Research on patent quality of Chinese listed traditional Chinese medicine enterprises from R&D investment perspective].
    Cao YD; Gong RJ; Chen N; Liu W
    Zhongguo Zhong Yao Za Zhi; 2019 Mar; 44(6):1284-1288. PubMed ID: 30989996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Response to US review rules on patent subject matter of traditional Chinese medicine compositions].
    Liu P; Cao YD; Gong RJ; Liu W
    Zhongguo Zhong Yao Za Zhi; 2018 Feb; 43(3):627-630. PubMed ID: 29600632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current quality research situation of precious Chinese patent medicine].
    Lin L; Liu XQ; Xu H
    Zhongguo Zhong Yao Za Zhi; 2008 Feb; 33(3):329-33. PubMed ID: 18536475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cluster analysis on authorized patents of compound traditional Chinese medicines with different efficacy in 2010].
    Yang X; Xiao S; Guo Z
    Zhongguo Zhong Yao Za Zhi; 2012 Aug; 37(16):2478-82. PubMed ID: 23234154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intellectual property protection in the natural product drug discovery, traditional herbal medicine and herbal medicinal products.
    Kartal M
    Phytother Res; 2007 Feb; 21(2):113-9. PubMed ID: 17117452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Market survey on traditional medicine of the third month fair in Dali Prefecture in Yunnan Province, South West China.
    Zhang D; Duan L; Zhou N
    Afr J Tradit Complement Altern Med; 2014; 11(2):377-401. PubMed ID: 25435625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.